Cargando…

Toll-like Receptors from the Perspective of Cancer Treatment

Toll-like receptors (TLRs) represent a family of pattern recognition receptors that recognize certain pathogen-associated molecular patterns and damage-associated molecular patterns. TLRs are highly interesting to researchers including immunologists because of the involvement in various diseases inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javaid, Nasir, Choi, Sangdun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072551/ https://www.ncbi.nlm.nih.gov/pubmed/32012718 http://dx.doi.org/10.3390/cancers12020297

Ejemplares similares

Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
por: Javaid, Nasir, et al.
Publicado: (2019)

Negative regulatory approaches to the attenuation of Toll-like receptor signaling
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2013)

Recent clinical trends in Toll‐like receptor targeting therapeutics
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2018)

Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)

Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
por: Yesudhas, Dhanusha, et al.
Publicado: (2014)

Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach
por: Manan, Abdul, et al.
Publicado: (2022)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Toll-like Receptor-Dependent Negative Effects of Opioids: A Battle between Analgesia and Hyperalgesia
por: Shah, Masaud, et al.
Publicado: (2017)

Unraveling the Tomaralimab Epitope on the Toll-like Receptor 2 via Molecular Dynamics and Deep Learning
por: Ahmad, Bilal, et al.
Publicado: (2022)

Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets
por: Javaid, Nasir, et al.
Publicado: (2017)

Structure and dynamic behavior of Toll‐like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum
por: Durai, Prasannavenkatesh, et al.
Publicado: (2013)

The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions
por: Pirzada, Rameez Hassan, et al.
Publicado: (2020)

In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L
por: Basith, Shaherin, et al.
Publicado: (2011)

Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2011)

A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer
por: Patra, Mahesh Chandra, et al.
Publicado: (2020)

Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2010)

CRISPR/Cas System and Factors Affecting Its Precision and Efficiency
por: Javaid, Nasir, et al.
Publicado: (2021)

An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool
por: Javaid, Nasir, et al.
Publicado: (2022)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Computational Insight Into the Structural Organization of Full-Length Toll-Like Receptor 4 Dimer in a Model Phospholipid Bilayer
por: Patra, Mahesh Chandra, et al.
Publicado: (2018)

Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity
por: Sumneang, Natticha, et al.
Publicado: (2023)

Targeting Toll-Like Receptors for Treatment of SLE
por: Horton, Christopher G., et al.
Publicado: (2010)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

The application of Toll like receptors for cancer therapy
por: So, Eui Young, et al.
Publicado: (2010)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model
por: Baek, Wook-Young, et al.
Publicado: (2021)

Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
por: Giurini, Eileena F., et al.
Publicado: (2022)

Therapeutic Interventions into Innate Immune Diseases by Means of Aptamers
por: Yasmeen, Farzana, et al.
Publicado: (2020)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-like receptors and NOD-like receptors in rheumatic diseases
por: McCormack, William J, et al.
Publicado: (2009)

Roles of toll-like receptors: From inflammation to lung cancer progression
por: Gu, Jinjing, et al.
Publicado: (2018)

Toll-like receptor downstream signaling
por: Kawai, Taro, et al.
Publicado: (2005)

Toll-like receptor 4 in atherosclerosis
por: Li, Hongli, et al.
Publicado: (2007)

Toll-like receptors in lupus nephritis
por: Devarapu, Satish Kumar, et al.
Publicado: (2018)

The Role of Toll-Like Receptors in Oncotherapy
por: Liu, Caiqi, et al.
Publicado: (2019)

Toll-like Receptors in Viral Encephalitis
por: Gern, Olivia Luise, et al.
Publicado: (2021)

Toll-like Receptors and Celiac Disease
por: Talipova, Diana, et al.
Publicado: (2022)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
por: Wolska, Anna, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_amekuce8errledlce11utmdeam